New camera aims to help surgeons spot brain tumor cells
NCT ID NCT07021573
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a special camera attached to a surgical microscope to see if it can better detect glioma tumor cells during brain surgery. Researchers will observe 80 adults with suspected high-grade gliomas. The goal is to improve how surgeons see tumor tissue, not to test a new drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better visualization of tumor cells during surgery, helping surgeons remove more of the tumor.
- What could go wrong
- This is an early observational study, not a treatment trial. The new imaging may not improve outcomes or could be impractical in real surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, Germany
-
Hôpitaux universitaires de Genève - NeuroCentre
Geneva, Switzerland
-
Inselspital Bern, Universitätsklinik für Neurochirurgie
Bern, Switzerland
-
Klinik und Poliklinik für Neurochirurgie, LMU Klinikum München
München, Germany
-
Klinikum rechts der Isar der Technischen Universität München
München, Germany
-
Universitätsklinik für Neurochirurgie der Medizinischen Universität Innsbruck
Innsbruck, Austria
-
Universitätsklinikum Freiburg - Klinik für Neurochirurgie im Neurozentrum
Freiburg im Breisgau, Germany
-
Universitätsklinikum Göttingen - Neurochirurgische Klinik
Göttingen, Germany
-
Universitätsklinikum Münster - Klinik für Neurochirurgie
Münster, Germany
-
Universitätsklinikum Tübingen, Universitätsklinik für Neurochirurgie
Tübingen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Could cutting a wider margin around brain tumors extend survival?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a 7-Week brain tumor treatment beat the standard 10-Week plan?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?